Holders over time
- VCYT
- ELV
| Quarter | VCYT | ELV |
|---|---|---|
| Q3 2020 | 4 holders, $483m | 30 holders, $15.0bn |
| Q4 2020 | 4 holders, $790m | 29 holders, $16.7bn |
| Q1 2021 | 4 holders, $891m | 25 holders, $18.6bn |
| Q2 2021 | 4 holders, $480m | 30 holders, $19.4bn |
| Q3 2021 | 4 holders, $816m | 26 holders, $18.5bn |
| Q4 2021 | 4 holders, $760m | 29 holders, $23.3bn |
| Q1 2022 | 5 holders, $376m | 31 holders, $23.9bn |
| Q2 2022 | 3 holders, $233m | 32 holders, $23.3bn |
| Q3 2022 | 2 holders, $214m | 34 holders, $22.6bn |
| Q4 2022 | 4 holders, $452m | 34 holders, $25.5bn |
| Q1 2023 | 4 holders, $430m | 39 holders, $22.5bn |
| Q2 2023 | 5 holders, $503m | 38 holders, $20.6bn |
| Q3 2023 | 5 holders, $406m | 34 holders, $19.8bn |
| Q4 2023 | 4 holders, $496m | 36 holders, $20.3bn |
| Q1 2024 | 3 holders, $388m | 35 holders, $21.3bn |
| Q2 2024 | 4 holders, $380m | 33 holders, $22.1bn |
| Q3 2024 | 5 holders, $510m | 30 holders, $20.2bn |
| Q4 2024 | 7 holders, $657m | 32 holders, $15.9bn |
| Q1 2025 | 4 holders, $388m | 28 holders, $17.1bn |
| Q2 2025 | 3 holders, $278m | 27 holders, $14.8bn |
| Q3 2025 | 3 holders, $407m | 27 holders, $12.7bn |
| Q4 2025 | 4 holders, $429m | 25 holders, $17.0bn |
| Q1 2026 | 4 holders, $278m | 26 holders, $13.6bn |
| Q2 2026 | 7 holders, $663m | 28 holders, $17.7bn |
Veracyte Inc
- Holders
- 3
- Reported value
- $278m
- Buyers
- 2
- Sellers
- 2
Breadth 0 among 95 comparable managers.
Elevance Health Inc Formerly
- Holders
- 27
- Reported value
- $14.8bn
- Buyers
- 13
- Sellers
- 16
Breadth -3 among 95 comparable managers.
Who holds both, Q2 2025
Only VCYT (1)
Only ELV (25)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Baillie Gifford & Co, Baupost Group LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Fidelity (FMR LLC), First Eagle Investment Management LLC, Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, MFS Investment Management, Moore Capital Management LP, Ruane Cunniff & Goldfarb LP, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Investments LP, Wellington Management Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.